Director TitleAgeSince
Chairman - -
Chairman - 2012-06-27
Director/Board Member - 2012-12-23
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+0.21%-4.63%+55.34%+71.32% 68.98B
-3.40%+0.60%+3.04%+55.91% 53.15B
-0.46%+5.56%+10.18%+41.75% 50.83B
-0.83%+3.78%+31.08%+35.54% 44.61B
-3.74%-3.88%+267.14%+434.57% 40.57B
-1.42%+4.07%+15.99%+112.07% 42.53B
+1.28%+1.39%+11.69%+45.10% 30.95B
-0.90%-10.49%+31.48%-1.63% 25.44B
-1.67%-8.52%-15.59%-8.53% 22.66B
Average -0.94%+1.56%+45.59%+87.35% 42.19B
Weighted average by Cap. -1.20%+2.33%+47.95%+92.58%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock